Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opus Genetics (IRD) Share-based Compensation (2020 - 2026)

Opus Genetics has reported Share-based Compensation over the past 12 years, most recently at $1.5 million for Q1 2026.

  • Quarterly Share-based Compensation rose 60.35% to $1.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $651000.0 through Mar 2026, down 86.66% year-over-year, with the annual reading at $100000.0 for FY2025, 97.03% down from the prior year.
  • Share-based Compensation was $1.5 million for Q1 2026 at Opus Genetics, up from -$2.5 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $247.0 million in Q1 2023 and troughed at -$2.5 million in Q4 2025.
  • The 5-year median for Share-based Compensation is $758500.0 (2023), against an average of $16.0 million.
  • Year-over-year, Share-based Compensation crashed 356.58% in 2022 and then skyrocketed 55405.62% in 2023.
  • A 5-year view of Share-based Compensation shows it stood at -$1.2 million in 2022, then soared by 157.85% to $711000.0 in 2023, then soared by 344.73% to $3.2 million in 2024, then plummeted by 179.85% to -$2.5 million in 2025, then skyrocketed by 157.98% to $1.5 million in 2026.
  • Per Business Quant, the three most recent readings for IRD's Share-based Compensation are $1.5 million (Q1 2026), -$2.5 million (Q4 2025), and $816000.0 (Q3 2025).